Method of treating anxiety-related disorders using sertraline
Patent 4962128 Issued on October 9, 1990. Estimated Expiration Date: 
November 2, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 2, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAntidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine Patent #: 4536518 InventorsApplicationNo. 431000 filed on 11/02/1989US Classes:514/647Amino nitrogen and a ring bonded directly to the same ring and any other amino nitrogen in the compound is bonded directly to one of the ringsExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassA61K 031/135AbstractA method of treating anxiety-related disorders comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in preventing or alleviating anxiety and the symptoms associated with anxiety-related disorders. | |
